Silynxcom (SYNX) director discloses options for 26,840 shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Silynxcom Ltd. director Efrat Itiel has reported existing derivative holdings in a Form 3. The filing shows share options giving the right to buy 26,840 ordinary shares at an exercise price of 4.0000 per share, expiring on January 31, 2029. These options were granted on January 31, 2024 and vest in three equal annual installments starting January 30, 2025 through January 30, 2027. The entry reflects holdings only, with no reported purchases or sales of shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Efrat Itiel
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Share options (right to buy) — 26,840 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What does Silynxcom (SYNX) director Efrat Itiel report in this Form 3?
Efrat Itiel reports existing holdings of share options in Silynxcom Ltd. The Form 3 lists options to acquire 26,840 ordinary shares, documenting her derivative position as a director rather than any new share purchase or sale.
How do Efrat Itiel’s Silynxcom (SYNX) options vest over time?
The options vest in three equal annual installments. Vesting begins on January 30, 2025 and continues annually until January 30, 2027, meaning one-third of the grant becomes exercisable on each of those dates.
Does this Silynxcom (SYNX) Form 3 show any insider buying or selling?
The Form 3 does not show any insider buying or selling activity. It records a holding entry for share options only, with no reported transactions changing the number of shares or options owned on the reported date.